138 related articles for article (PubMed ID: 34604305)
1. Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma.
Chen X; Li C; Li Y; Wu S; Liu W; Lin T; Li M; Weng Y; Lin W; Qiu S
Front Mol Biosci; 2021; 8():727481. PubMed ID: 34604305
[TBL] [Abstract][Full Text] [Related]
2. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
Front Oncol; 2021; 11():650534. PubMed ID: 33996568
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Potential of METTL7B in Glioma.
Fu R; Luo X; Ding Y; Guo S
Neuroimmunomodulation; 2022; 29(3):186-201. PubMed ID: 35034026
[TBL] [Abstract][Full Text] [Related]
4. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.
Jiang Z; Yin W; Zhu H; Tan J; Guo Y; Xin Z; Zhou Q; Cao Y; Wu Z; Kuang Y; Li C; Xie D; Huang H; Zhao M; Jiang X; Wang L; Ren C
Cancer Cell Int; 2021 Jul; 21(1):383. PubMed ID: 34281539
[TBL] [Abstract][Full Text] [Related]
5. A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
Luo C; Wang S; Shan W; Liao W; Zhang S; Wang Y; Xin Q; Yang T; Hu S; Xie W; Xu N; Zhang Y
Front Immunol; 2022; 13():909189. PubMed ID: 35769464
[TBL] [Abstract][Full Text] [Related]
6. METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells.
Li R; Mu C; Cao Y; Fan Y
Ann Transl Med; 2022 Aug; 10(16):895. PubMed ID: 36110989
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells
Li W; Xu S; Peng N; Zhang Z; He H; Chen R; Chen D; Fan J; Wang X
Front Oncol; 2021; 11():634542. PubMed ID: 33718220
[TBL] [Abstract][Full Text] [Related]
8. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma.
Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q
Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.
Lin W; Wu S; Chen X; Ye Y; Weng Y; Pan Y; Chen Z; Chen L; Qiu X; Qiu S
Front Oncol; 2020; 10():796. PubMed ID: 32500034
[TBL] [Abstract][Full Text] [Related]
10. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
11. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
12. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
[TBL] [Abstract][Full Text] [Related]
14. METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer.
Liu D; Li W; Zhong F; Yin J; Zhou W; Li S; Sun X; Xu J; Li G; Wen Y; Wang J; Hong M; Cheng Z; Yuan J; Dai L; Sun J; Wang J; Qiu C; Wang G; Zou C
Front Pharmacol; 2020; 11():178. PubMed ID: 32180726
[TBL] [Abstract][Full Text] [Related]
15. Prognosis Analysis and Validation of m
Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M
Front Oncol; 2020; 10():541401. PubMed ID: 33123464
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.
Wang QW; Zhao Z; Bao ZS; Jiang T; Zhu YJ
Am J Cancer Res; 2021; 11(4):1226-1246. PubMed ID: 33948355
[TBL] [Abstract][Full Text] [Related]
17. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
Xia P; Li Q; Wu G; Huang Y
Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.
Li Y; Deng G; Qi Y; Zhang H; Gao L; Jiang H; Ye Z; Liu B; Chen Q
Med Sci Monit; 2020 Aug; 26():e924054. PubMed ID: 32843610
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
Front Immunol; 2021; 12():557994. PubMed ID: 34220791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
